Written answers
Tuesday, 7 November 2023
Department of Health
Medicinal Products
Colm Burke (Cork North Central, Fine Gael)
Link to this: Individually | In context | Oireachtas source
1364. To ask the Minister for Health the status of Pembrolizumab, used in the treatment of triple negative breast cancer (details supplied); and if he will make a statement on the matter. [48793/23]
Stephen Donnelly (Wicklow, Fianna Fail)
Link to this: Individually | In context | Oireachtas source
Under the Health (Pricing and Supply of Medical Goods) Act 2013, the HSE has statutory responsibility for decisions on the pricing and reimbursement of medicines; therefore, the matter has been referred to the HSE for attention and direct reply to the Deputy.
No comments